Search
for
Sort by
Research 151–180 of 1000+
- Associations between transition‐specific stress experience, nocturnal decline in ambulatory blood pressure, and C‐reactive protein levels among transgender men
- Nonclassic Congenital Adrenal Hyperplasia: An Overview
- Non-Neoplastic Disorders of Hair
- Adult polycystic ovary syndrome begins in childhood
- Congenital hypotrichosis due to short anagen
- Female pattern hair loss
- A comparative study on insulin resistance in females of reproductive age group with acne vulgaris
- A Case Report of Autoimmune Hemolytic Anemia with Deep Vein Thrombosis in a 16-year-old Girl - Is It Systemic Lupus Erythematosus?
- Male and female pattern hair loss: Treatable and worth treating
- Managing Dermatologic Effects of Gender-Affirming Therapy in Transgender Adolescents
- Association of Acne Tarda with Endocrinological Disorders
- Hair Loss in Children, Etiologies, and Treatment
- Stroke Risk Factors Unique to Women
- Hidradenitis suppurativa: A comparison of guidelines
- Considerations for Providing Pediatric Gender-Affirmative Care During the COVID-19 Pandemic
- The Need and Management of hormone Imbalances in Women
- Two females with hair loss
- Hidradenitis suppurativa/Acne inversa: an endocrine skin disorder?
- Developmental origin of polycystic ovary syndrome - a hypothesis
- Update on Hidradenitis Suppurativa (Part I): Epidemiology, Pathogenesis, Severity assessment and Comorbidities
- Endocrinologic Aspects of Hidradenitis Suppurativa
- Androgenic Alopecia
- Hyperandrogenism in Adolescent Girls
- Acne keloidalis nuchae: prevalence, impact, and management challenges
- Diagnosis and Challenges of Polycystic Ovary Syndrome in Adolescence
- Pediatric Endocrine-Disrupting Chemical Exposure Produces Irreversible Organizational Injury: Biomarker Evidence Necessitating a Precautionary Public Health Framework
- Hair Changes Caused by Aging
- Insulin Resistance and Polycystic Ovary Syndrome
- Hormonal and Surgical Treatment Options for Transgender Men (Female-to-Male)
- Insights learned from L457(3.43)R, an activating mutant of the human lutropin receptor